HF Logo HF Logo Provider Portal Login
Provider Home / Pharmacy Resources & Formularies
Resource Type
Clear All
Filter
Year
Sort By
Showing 1-12 of 23
Provider Alerts - Pharmacy Resources & Formularies - Practice Guidelines and Tips - 2025
Obtaining Physician-Administered Drugs through a Specialty Pharmacy

As a Healthfirst provider, you can get Physician-Administered Drugs (PADs) delivered to your office at no cost through White Bagging when the medication is obtained from a Healthfirst in-network specialty pharmacy provider.

Open document
Pharmacy
  
Provider Alerts - Pharmacy Resources & Formularies - Policy, Billing, or Coverage Update - 2025
Reimbursement Update for Contrast Agents Prescribed to Medicaid Members

To align with the New York State Medicaid Pharmacy Program policies, Healthfirst will no longer reimburse any contrast agents used for radiological testing for members enrolled in Medicaid Managed Care (MMC) or Personal Wellness Plans (HARP).

Open external link
Pharmacy
Medicaid
  
Pharmacy Resources & Formularies - Provider Resources - 2025
Prior Authorization Pharmacy Medical Benefit Grid

It is the policy of Healthfirst to require prior authorization for medical claims for all medications listed within this document. To learn more, including ways to submit prior authorization, access this resource.

Open external link
Authorization
  
Provider Alerts - Pharmacy Resources & Formularies - Claims & Billing - Policy, Billing, or Coverage Update - 2025
New Physician Dispenser Policy

New York State Department of Health has requested that Healthfirst notify practitioners of this change and inform them that they will need to bill claims through the Medical benefit after September 1, 2022, to be reimbursed.

View Post
Administration
  
Provider Alerts - Pharmacy Resources & Formularies - Coronavirus (COVID-19) - Provider Resources - 2023
Pharmacy Billing Guidance for COVID-19 Vaccine Under Healthfirst’s Medicaid Managed Care Plan (MMC) and Personal Wellness Plan

During the declared State of New York disaster emergency, pharmacies may bill for COVID-19 vaccines that have been authorized by the FDA under Emergency Use Authorization (EUA) under Healthfirst’s Medicaid Managed Care Plan (MMC) and Personal Wellness Plan (PWP). View PDF for billing instructions.

Open document
Personal Wellness Plan
  
Provider Alerts - Pharmacy Resources & Formularies - Coronavirus (COVID-19) - Provider Resources - 2023
COVID-19 Vaccine Additional Doses for Immunocompromised Individuals Pharmacy Billing Guidance

On August 13, 2021, the Advisory Committee on Immunization Practices (ACIP) met and recommended an additional dose for immunocompromised individuals who have received the Pfizer-BioNTech or Moderna COVID-19 vaccine.

Open document
Emergency Use Authorization
  
Provider Alerts - Pharmacy Resources & Formularies - Coronavirus (COVID-19) - Provider Resources - 2023
Pfizer-BioNtech, and Moderna, COVID-19 Booster Update Pharmacy Billing Guidance

The U.S. Food and Drug Administration has amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine to allow for a booster dose. Consult the individual EUA’s for current guidance.

Open document
Emergency Use Authorization
  
Provider Alerts - Pharmacy Resources & Formularies - Coronavirus (COVID-19) - Provider Resources - 2023
Zero-Cost COVID-19 Oral Antivirals Pharmacy Billing Guidance

Claims that providers submit for zero-cost COVID-19 oral antivirals must have either $0.01 in the Ingredient Cost Submitted field (NCPDP field 4Ø9-D9) or the combination of $0.00 in the Ingredient Cost Submitted field (NCPDP field 4Ø9-D9) and a value of “15” in the Basis of Cost Determination field (NCPDP field 423-DN).

Open document
Pharmacy Billing
  
Provider Alerts - Pharmacy Resources & Formularies - Coronavirus (COVID-19) - Provider Resources - 2023
New York Medicaid Guidance for At-Home COVID-19 Testing Coverage Update

Implementation of adjudication coding for at-home testing coverage for most New York Medicaid Managed Care Plan Sponsors should be completed by January 17, 2022. Providers receiving a reject message (e.g., reject code: 70 - NDC not covered, etc.) on COVID-19 at-home testing claims filled prior to January 17, 2022, should re-submit rejected claims after January 17, 2022.

Open document
Pharmacy Billing
  
Provider Alerts - Pharmacy Resources & Formularies - Coronavirus (COVID-19) - Provider Resources - 2023
New York State Medicaid Coverage Criteria for Pharmacists Providing COVID-19 Vaccine Counseling

The New York State Department of Health issued guidance that New York State Medicaid will reimburse COVID-19 vaccination counseling to Medicaid members/enrollees by pharmacists in order to encourage vaccination against COVID-19. The effective date of coverage is for dates of service on or after December 1, 2021.

Open document
Medicaid
  
Provider Alerts - Pharmacy Resources & Formularies - Coronavirus (COVID-19) - Provider Resources - 2023
New York Medicaid COVID-19 Vaccine Claims Submission Reminder

This information is being provided to assist your pharmacy with the submission of COVID-19 vaccine administration claims. The content of this communication is for informational purposes only and is not intended as a substitute for the information provided in the COVID-19 Vaccine Administration Network Enrollment Form.

Open document
Medicaid
  
Provider Alerts - Pharmacy Resources & Formularies - Provider Resources - 2023
Vyondys 53, Exondys 51, Amondys 45 and Viltepso Criteria

This policy is to provide guidance on the coverage guidelines utilized to review the request for prior authorization for Vyondys 53™ (golodirsen), Exondys 51™ (eteplirsen), Amondys 45™ (casimersen) and Viltepso™ (viltolarsen). These coverage guidelines will be used to determine medical necessity.

Open document
Prior Authorization
  
You are now navigating away from the Healthfirst website.

Links to non-Healthfirst websites are provided for your convenience only. Healthfirst is not responsible or liable for the content, accuracy, or privacy practices of linked sites, or for products or services described on these sites.